Literature DB >> 2717690

Possible active components of tan-shen (Salvia miltiorrhiza) for protection of the myocardium against ischemia-induced derangements.

A Yagi, K Fujimoto, K Tanonaka, K Hirai, S Takeo.   

Abstract

Extract of Tan-Shen (Salvia miltiorrhiza, Labiatae), a Chinese traditional crude drug, was reported to show beneficial activity for heart disease. Chemical examination on the extract was performed on the basis of screening for protective action on the ischemic myocardium. Isolated hearts were subjected to hypoxic perfusion for 20 min, followed by 45 min reoxygenation, and the recovery of cardiac contractile force and changes in UV absorbance of the perfusate were examined. Among the components isolated, tanshinone I, cryptotanshinone, and tanshinone VI elicited a significant enhanced recovery of the contractile force upon reoxygenation. This was associated with a decrease in the increase in UV absorbance of the perfusate, suggesting the preservation of ATP metabolites in the myocardium. This, in turn, may enhance the restoration of ATP upon oxygen-replenishment. The results suggest that tanshinone I, cryptotanshinone, and tanshinone VI can protect the myocardium against ischemia-induced derangements.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2717690     DOI: 10.1055/s-2006-961824

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  17 in total

1.  Salvia miltiorrhiza water-soluble extract, but not its constituent salvianolic acid B, abrogates LPS-induced NF-kappaB signalling in intestinal epithelial cells.

Authors:  J S Kim; A S Narula; C Jobin
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

2.  Effect of magnesium tanshinoate B on the production of nitric oxide in endothelial cells.

Authors:  K O; F Cheung; F L Sung; D Y Zhu; Y L Siow
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

3.  Salvianolate inhibits cytokine gene expression in small intestine of cirrhotic rats.

Authors:  Dan-Hong Yang; Zai-Yuan Ye; Bo Jin; Xu-Jun He; Qin Zhang; Wei-Ming Zhou; Wen-Juan Xu; Huo-Xiang Lu
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

4.  Effect of salvianolate on intestinal epithelium tight junction protein zonula occludens protein 1 in cirrhotic rats.

Authors:  Dan-Hong Yang; Zai-Yuan Ye; Yuan-Jun Xie; Xu-Jun He; Wen-Juan Xu; Wei-Ming Zhou
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

5.  3,9-Dimethyl-2,3-dihydro-phenanthro[1,2-b]furan-4,5-dione.

Authors:  Jing-Cai Yao; Zhong-Dong Wang; Jin-Bo Guo; Li Zhang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-11-18

6.  Effects of tanshinone VI on insulin-like growth factor-1-induced hypertrophy of isolated cardiomyocytes from neonatal rats.

Authors:  Yuji Kawahara; Kouichi Tanonaka; Toru Arino; Toshiyuki Maki; Naoko Ishihara; Norio Takagi; Akira Yagi; Satoshi Takeo
Journal:  Exp Clin Cardiol       Date:  2004

7.  In silico analysis and experimental validation of molecular mechanisms of salvianolic acid A-inhibited LPS-stimulated inflammation, in RAW264.7 macrophages.

Authors:  J Huang; Y Qin; B Liu; G Y Li; L Ouyang; J H Wang
Journal:  Cell Prolif       Date:  2013-08-24       Impact factor: 6.831

Review 8.  Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.

Authors:  Zhuo-Ming Li; Suo-Wen Xu; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

9.  Therapeutic effects of water soluble danshen extracts on atherosclerosis.

Authors:  Yoon Hee Cho; Cheol Ryong Ku; Zhen-Yu Hong; Ji Hoe Heo; Eun Hee Kim; Dong Hoon Choi; Dongkyu Kim; Ae-Jung Kim; Cheol Soon Lee; Mankil Jung; Hyun Chul Lee; Miran Seo; Eun Jig Lee
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-16       Impact factor: 2.629

10.  A systems biology approach to uncovering pharmacological synergy in herbal medicines with applications to cardiovascular disease.

Authors:  Xia Wang; Xue Xu; Weiyang Tao; Yan Li; Yonghua Wang; Ling Yang
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-29       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.